EP1558648A4
Human monoclonal antibodies against cd20
82 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0009160A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-40,44 |
| WO0222212A2 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-37,41-44 |
| US2002009427A1 | Cites | United States of America | XY | Search report | 1-40,44 |
| US5770429A | Cites | United States of America | YD | Search report | 1-44 |
| US6120767A | Cites | United States of America | Y | Search report | 1-40,44 |
| WO9411026A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-40,44 |
| WO0222212A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO9411026A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| WO0009160A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| GAZZANO-SANTORO H ET AL: "A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 202, no. 2, 28 March 1997 (1997-03-28), pages 163 - 171, XP004126276, ISSN: 0022-1759 | Non-patent | – | – | Search report | – |
| EDWARDS J C W ET AL: "Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes", RHEUMATOLOGY, OXFORD UNIVERSITY PRESS, LONDON, GB, vol. 40, no. 2, February 2001 (2001-02-01), pages 205 - 211, XP002348931, ISSN: 1462-0324 | Non-patent | – | – | Search report | – |
| VAN SPRIEL A B ET AL: "Immunotherapeutic perspective for bispecific antibodies", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 8, 1 August 2000 (2000-08-01), pages 391 - 397, XP004215167, ISSN: 0167-5699 | Non-patent | – | – | Search report | – |
| See also references of WO 2004035607A2 | Non-patent | – | – | Search report | – |
93 members in 26 offices
Members93
| Document | Office | Kind | |
|---|---|---|---|
| CA2502552A1 | Canada | A1 | |
| CA3029035A1 | Canada | A1 | |
| WO2004035607A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003301445A1 | Australia | A1 | |
| WO2004035607A8 | World Intellectual Property Organization (WIPO) | A8 | |
| WO2004035607A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2004167319A1 | United States of America | A1 | |
| KR20050049552A | Republic of Korea | A | |
| EP1558648A2 | European Patent Office (EPO) | A2 | |
| BR0315295A | Brazil | A | |
| MXPA05004022A | Mexico | A | |
| PL376351A1 | Poland | A1 | |
| CN1729203A | China | A | |
| EP1558648A4This record | European Patent Office (EPO) | A4 | |
| HK1077590A1 | Hong Kong, China | A1 | |
| EA200500679A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2006507844A | Japan | A | |
| KR20080090565A | Republic of Korea | A | |
| IL167851D0 | Israel | D0 | |
| KR20090088973A | Republic of Korea | A | |
| KR100932340B1 | Republic of Korea | B1 | |
| JP2010042002A | Japan | A | |
| KR100944575B1 | Republic of Korea | B1 | |
| NZ568769A | New Zealand | A | |
| KR20100050587A | Republic of Korea | A | |
| CN101928344A | China | A | |
| KR20110017020A | Republic of Korea | A | |
| UA93478C2 | Ukraine | C2 | |
| JP4662473B2 | Japan | B2 | |
| EP2316856A1 | European Patent Office (EPO) | A1 | |
| EP2330130A1 | European Patent Office (EPO) | A1 | |
| AU2011202520A1 | Australia | A1 | |
| NZ581541A | New Zealand | A | |
| KR20110140142A | Republic of Korea | A | |
| EP1558648B1 | European Patent Office (EPO) | B1 | |
| JP2012005485A | Japan | A | |
| AT540978T | Austria | T | |
| ATE540978T1 | Austria | T1 | |
| DK1558648T3 | Denmark | T3 | |
| PT1558648E | Portugal | E | |
| ES2380621T3 | Spain | T3 | |
| SI1558648T1 | Slovenia | T1 | |
| IL221193D0 | Israel | D0 | |
| KR20120128151A | Republic of Korea | A | |
| AU2011202520B2 | Australia | B2 | |
| AU2012268852A1 | Australia | A1 | |
| JP5155968B2 | Japan | B2 | |
| PL402418A1 | Poland | A1 | |
| US8529902B2 | United States of America | B2 | |
| IL167851A | Israel | A | |
| KR101348472B1 | Republic of Korea | B1 | |
| LU92041I2 | Luxembourg | I2 | |
| CN1729203B | China | B | |
| US2014093454A1 | United States of America | A1 | |
| CN103709250A | China | A | |
| PL216630B1 | Poland | B1 | |
| CN101928344B | China | B | |
| EP2330130B1 | European Patent Office (EPO) | B1 | |
| ES2524694T3 | Spain | T3 | |
| PL218660B1 | Poland | B1 | |
| EA201492217A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CY1112750T1 | Cyprus | T1 | |
| CY2012019I1 | Cyprus | I1 | |
| CY2012019I2 | Cyprus | I2 | |
| AU2015205832A1 | Australia | A1 | |
| JP5767041B2 | Japan | B2 | |
| EA021644B1 | Eurasian Patent Organization (EAPO) | B1 | |
| UA109629C2 | Ukraine | C2 | |
| AU2011202520C1 | Australia | C1 | |
| CN103709250B | China | B | |
| AU2017204254A1 | Australia | A1 | |
| EP2316856B1 | European Patent Office (EPO) | B1 | |
| EP3284753A2 | European Patent Office (EPO) | A2 | |
| EP3284753A3 | European Patent Office (EPO) | A3 | |
| BRPI0315295B1 | Brazil | B1 | |
| LU92041I9 | Luxembourg | I9 | |
| CA2502552C | Canada | C | |
| EP3284753B1 | European Patent Office (EPO) | B1 | |
| AU2019204903A1 | Australia | A1 | |
| BRPI0315295B8 | Brazil | B8 | |
| ES2744275T3 | Spain | T3 | |
| HUE046695T2 | Hungary | T2 | |
| PT3284753T | Portugal | T | |
| LT3284753T | Lithuania | T | |
| US2020317799A1 | United States of America | A1 | |
| BRPI0315295C1 | Brazil | C1 | |
| DK3284753T3 | Denmark | T3 | |
| AU2019204903B2 | Australia | B2 | |
| LTPA2021514I1 | Lithuania | I1 | |
| HUS2100026I1 | Hungary | I1 | |
| FR21C1028I1 | France | I1 | |
| LTC3284753I2 | Lithuania | I2 | |
| CA3029035C | Canada | C |
144 legal events, as 24 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Restoration of lapsed rightLapsedNF | NF | GR | |
| Nullification of an spcSPCN | SPCN | AT | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Revocation of the patentMA03 | MA03 | AT | |
| Supplementary protection certificate is invalid as the basic patent has ceased before the 20-year protection periodCeasedSPCC | SPCC | SE | |
| Supplementary protection certificate deletionSPCL | SPCL | CH | |
| Patent revokedRevokedMA9A | MA9A | LT | |
| Withdrawal of an spcSPCW | SPCW | LT | |
| Supplementary protection certificate invalidSPCI | SPCI | SI | |
| Supplementary protection certificate declared invalidSPCI | SPCI | IE | |
| Declaration of invalidity of an spc by reason of revocation or limitation of basic patentSPCI | SPCI | SK | |
| Annulment of patentMC4A | MC4A | SK | |
| Annulment of an spcMC1Y | MC1Y | EE | |
| Right revoked following opposition or revocationRevokedMF4A | MF4A | EE | |
| Epo's revocation decision now finalR064 | R064 | DE | |
| Patent revoked by epoRevokedR103 | R103 | DE | |
| Request for revocation filed after opposition period found admissibleOppositionRVAA | RVAA | EP | |
| Application to withdraw or offer to surrender a supplementary protection certificateCTFW | CTFW | GB | |
| Patent ceasedCeasedPL | PL | CH | |
| Request for revocation filed by patent holderORIGINAL CODE: EPIDOSNRVR6PLBU | PLBU | EP | |
| Decision on request for revocationORIGINAL CODE: EPIDOSNRVR3PLDH | PLDH | EP | |
| Patent revoked on request of proprietorRevokedORIGINAL CODE: 0009220RDAA | RDAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT REVOKED BY PROPRIETORSTAA | STAA | EP | |
| Application withdrawn or ip right abandoned [spc]WithdrawnS120 | S120 | DE | |
| Kind of request for revocation recordedORIGINAL CODE: EPIDOSNRVR2PLBR | PLBR | EP | |
| Request for revocation filed by patent holderORIGINAL CODE: EPIDOSNRVR1PLBT | PLBT | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: OPPOSITION REJECTEDSTAA | STAA | EP | |
| Revocation request received by epoR061 | R061 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Grant of an spcSPCG | SPCG | SK | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | RO | |
| Grant of an spcSPCG | SPCG | AT | |
| Fee paymentPLFP | PLFP | FR | |
| Supplementary protection certificate filedSPCF | SPCF | BE | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | FI | |
| Change/correction of name and/or address of the ownersHC | HC | LU | |
| Fee paymentPLFP | PLFP | FR | |
| Grant of a supplementary protection certificateSPCG | SPCG | NL | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | IE | |
| Supplementary protection certificate (spc) issuedCTFG | CTFG | DK | |
| Other action affecting the existence or the validity of an industrial property rightAV | AV | FR | |
| Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)GrantedCT | CT | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Spc grantedGrantedFG1Y | FG1Y | EE | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | CH | |
| Grant of an spcSPCG | SPCG | LT | |
| Grant of an spcSPCG | SPCG | LT | |
| Epo decision maintaining patent unamended now finalR100 | R100 | DE | |
| Opposition rejectedOpposition27O | 27O | EP | |
| Opposition rejectedOppositionORIGINAL CODE: 0009273PLBN | PLBN | EP | |
| Supplementary protection certificateCCP | CCP | LU | |
| Communication despatched that opposition was rejectedOppositionORIGINAL CODE: EPIDOSNREJ1PLCK | PLCK | EP | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | SI | |
| Supplementary protection certificate (spc) grantedGrantedSPCG | SPCG | IT | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB | PLBB | EP | |
| Opposition filed against patentOppositionR026 | R026 | DE | |
| Supplementary protection certificate grantedGrantedSPCG | SPCG | SE | |
| Opposition filedOpposition26 | 26 | EP | |
| Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX | PLAX | EP | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Spc filedAA1Y | AA1Y | EE | |
| Filing of an spcSPCF | SPCF | SK | |
| Application for supplementary protection certificate filedSPCF | SPCF | SI | |
| Application for supplementary protection certificate effectively filedR065 | R065 | DE | |
| Information on application for a supplementary protection certificateAA1S | AA1S | HU | |
| Filing an spcSPCF | SPCF | LT | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Application for supplementary protection certificate filedSPCF | SPCF | SE | |
| Application for supplementary protection certificate (spc) filedCTFF | CTFF | DK | |
| Supplementary protection certificate (spc) filedCP | CP | FR | |
| Standard patents granted in hong kongGrantedGR | GR | HK | |
| Supplementary protection certificate filedCTFF | CTFF | GB |
Showing 100 of 144
Numbers
- Publication
- 1558648
- Application
- 38091450
Titles3
- German
- HUMANE MONOKLONALE ANTIKÖRPER GEGEN CD20
- English
- HUMAN MONOCLONAL ANTIBODIES AGAINST CD20
- French
- ANTICORPS MONOCLONAUX HUMAINS ANTI-CD20
Classification
- CPC, 48
- C07K16/2887
- C07K16/28
- A61K2039/505
- C07K16/4258
- C07K2317/21
- C07K2317/54
- C07K2317/56
- C07K2317/72
- C07K2317/732
- C07K2317/734
- C07K2317/92
- A61P1/00
- A61P1/04
- A61P11/00
- A61P11/06
- A61P13/12
- A61P17/00
- A61P17/06
- A61P17/08
- A61P19/02
- A61P21/04
- A61P25/00
- A61P25/28
- A61P27/02
- A61P29/00
- A61P31/18
- A61P31/20
- A61P31/22
- A61P35/00
- A61P35/02
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- A61P5/14
- A61P7/00
- A61P7/04
- A61P7/06
- A61P9/08
- A61P9/10
- A61P9/14
- A61P3/10
- C07K16/30
- C12N5/16
- A61K39/3955
- A61K45/06
- G01N33/686
- IPC, 7
- A61K39 00
- C07K16 28
- C07K16 42
- C12N5 22
- C12N5 24
- C07K16 30
- C12N15 63
Designated states31
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Albania
- Lithuania
- Latvia
- North Macedonia
